Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) the global specialty biopharmaceutical company is disappointed that the main thrust of the NICE Guidance stands in light of the judgment handed down today in Court by Judge Linda Dobbs.
Restrictions on the movement of livestock outside the current exclusion zone will be eased from midnight tonight, the UK Government has announced.
The UK Government is undertaking a “major effort” to “isolate and control” the foot and mouth outbreak in Surrey, the Prime Minister has said.
Gordon Brown has promised that the Government will “contain and control” the outbreak of foot and mouth disease on a Surrey farm.
As we develop, the company we keep may be increasingly influenced by our genes, according to a new study led by Virginia Commonwealth University researchers.
As part of its broad commitment to improving access to medicines, GlaxoSmithKline announced it has given consent through Canada?s Access to Medicines Regime to enable a Canadian company (Apotex) to manufacture a generic fixed dose combination (FDC) antiretroviral (ARV), containing two molecules over which GSK has patent rights (zidovudine and lamivudine) for the treatment of HIV/AIDS in Rwanda.
Business solution provider Accentia Technologies said it has bagged its first order worth euro 2.1 million (Rs 11.61 crore) in the UK for Hospital Process Management suite to improve the quality of clinical care.
Concussions are common in young athletes but the underlying changes in brain function that occur have been poorly understood. Now, a University of Pittsburgh School of Medicine study is the first to link changes in brain function directly to the recovery of the athlete. Results of the five-year study, funded by the National Institutes of Health, are published in the August issue of the scientific peer-reviewed journal, Neurosurgery, the official journal of the Congress of Neurological Surgeons.
GlaxoSmithKline (NYSE:GSK), one of the world?s largest vaccine manufacturers, announced that US health agency HHS has placed another order to purchase bulk H5N1 antigen for the US national stockpile of pre-pandemic vaccines. The company also announced the start of the first North American pre-pandemic vaccine trials in the company?s global pre-pandemic influenza program.
Geisinger Health System was recently named a 2007 Computerworld Honors Laureate, an honor that recognizes Geisinger?s innovations in using information technology in healthcare. The award was accepted on behalf of Geisinger by chief innovation and technology officer, Ronald A. Paulus, MD.